Suppr超能文献

一种新型剪接突变导致一个中国阿尔波特综合征家系中外显子14跳跃缺失

A Novel Splicing Mutation Causes Skipping of Exon 14 in a Chinese Family with Alport Syndrome.

作者信息

Gao Erzhi, Yang Xi, Si Nuo, Liu Keqiang, Wang Jin-Quan, Liu Zhihong

机构信息

National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.

McKusick-Zhang Center for Genetic Medicine, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

出版信息

Kidney Dis (Basel). 2020 Jan;6(1):43-49. doi: 10.1159/000502798. Epub 2019 Oct 22.

Abstract

BACKGROUND

Alport syndrome (AS) is an inherited progressive renal disease caused by mutations in , and . Although mutation screening in the genes responsible for AS is typically performed, only a small proportion of patients receive genetic testing in China, and the functional consequences of multiple splicing variants in AS patients have not been investigated.

METHODS

A family with X-linked AS was diagnosed based on family history and pathological findings from a kidney biopsy. Targeted next-generation sequencing was used to identify the causative mutation, and a minigene assay was performed to test the influence of the mutation on splicing.

RESULTS

A c.834+2T>G in was identified and shown to co-segregate with AS in the family. The variant is located in the canonical splicing site and is predicted to induce aberrant splicing. Minigene assay using HEK 293T cells indicated the skipping of exon 14 in -.

CONCLUSIONS

The novel splicing mutation identified in the current study broadened the genetic spectrum of X-linked AS and further deepened our insight of the disease's molecular mechanism.

摘要

背景

Alport综合征(AS)是一种由[基因名称1]、[基因名称2]和[基因名称3]突变引起的遗传性进行性肾病。尽管通常会对AS相关基因进行突变筛查,但在中国只有一小部分患者接受基因检测,且尚未对AS患者中多个剪接变异体的功能后果进行研究。

方法

根据家族病史和肾活检的病理结果诊断出一个X连锁AS家族。采用靶向二代测序来鉴定致病突变,并进行小基因检测以测试该突变对剪接的影响。

结果

在[基因名称1]中鉴定出一个c.834+2T>G突变,并显示在家族中与AS共分离。该变异位于典型剪接位点,预计会导致异常剪接。使用HEK 293T细胞进行的小基因检测表明,[基因名称1]中第14外显子跳跃。

结论

本研究中鉴定出的新型[基因名称1]剪接突变拓宽了X连锁AS的遗传谱,进一步加深了我们对该疾病分子机制的认识。

相似文献

1
A Novel Splicing Mutation Causes Skipping of Exon 14 in a Chinese Family with Alport Syndrome.
Kidney Dis (Basel). 2020 Jan;6(1):43-49. doi: 10.1159/000502798. Epub 2019 Oct 22.
2
Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Mol Genet Genomic Med. 2019 May;7(5):e647. doi: 10.1002/mgg3.647. Epub 2019 Mar 18.
4
Abnormal mRNA Splicing Effect of to Unclassified Variants.
Kidney Int Rep. 2023 Apr 10;8(7):1399-1406. doi: 10.1016/j.ekir.2023.04.001. eCollection 2023 Jul.
5
Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome.
BMC Med Genomics. 2023 Aug 18;16(1):192. doi: 10.1186/s12920-023-01623-7.
6
Molecular dynamics and minigene assay of new splicing variant c.4298-20T>A of gene that cause Alport syndrome.
Front Genet. 2023 Feb 27;14:1059322. doi: 10.3389/fgene.2023.1059322. eCollection 2023.
7
A novel COL4A5 splicing mutation causes alport syndrome in a Chinese family.
BMC Med Genomics. 2024 Apr 26;17(1):108. doi: 10.1186/s12920-024-01878-8.
8
Identification of 27 Novel Variants in Genes , and in Lithuanian Families With Alport Syndrome.
Front Med (Lausanne). 2022 Mar 28;9:859521. doi: 10.3389/fmed.2022.859521. eCollection 2022.
9
Three exonic variants in the COL4A5 gene alter RNA splicing in a minigene assay.
Mol Genet Genomic Med. 2024 Feb;12(2):e2395. doi: 10.1002/mgg3.2395.
10
A deep intronic splice variant of the gene in a Chinese family with X-linked Alport syndrome.
Front Pediatr. 2023 Jan 13;10:1009188. doi: 10.3389/fped.2022.1009188. eCollection 2022.

引用本文的文献

2
Molecular dynamics and minigene assay of new splicing variant c.4298-20T>A of gene that cause Alport syndrome.
Front Genet. 2023 Feb 27;14:1059322. doi: 10.3389/fgene.2023.1059322. eCollection 2023.
3
4
Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome.
Kidney Res Clin Pract. 2020 Dec 31;39(4):402-413. doi: 10.23876/j.krcp.20.111.

本文引用的文献

1
Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China.
Kidney Dis (Basel). 2018 Feb;4(1):10-19. doi: 10.1159/000484717. Epub 2017 Dec 8.
2
A Novel Splicing Mutation Identified in a Chinese Family with X-linked Alport Syndrome Using Targeted Next-Generation Sequencing.
Genet Test Mol Biomarkers. 2016 Apr;20(4):203-7. doi: 10.1089/gtmb.2015.0248. Epub 2016 Feb 11.
3
Evidence of digenic inheritance in Alport syndrome.
J Med Genet. 2015 Mar;52(3):163-74. doi: 10.1136/jmedgenet-2014-102822. Epub 2015 Jan 9.
4
Clinical utility gene card for: Alport syndrome - update 2014.
Eur J Hum Genet. 2015 Sep;23(9). doi: 10.1038/ejhg.2014.254. Epub 2014 Nov 12.
5
Improving mutation screening in familial hematuric nephropathies through next generation sequencing.
J Am Soc Nephrol. 2014 Dec;25(12):2740-51. doi: 10.1681/ASN.2013080912. Epub 2014 May 22.
7
Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome.
Clin J Am Soc Nephrol. 2013 May;8(5):749-55. doi: 10.2215/CJN.07510712. Epub 2013 Jan 31.
8
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Genome Res. 2010 Sep;20(9):1297-303. doi: 10.1101/gr.107524.110. Epub 2010 Jul 19.
9
Genotype-phenotype correlation in X-linked Alport syndrome.
J Am Soc Nephrol. 2010 May;21(5):876-83. doi: 10.1681/ASN.2009070784. Epub 2010 Apr 8.
10
Temporal bone histopathology in alport syndrome.
Laryngoscope. 2004 Sep;114(9):1609-18. doi: 10.1097/00005537-200409000-00020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验